Neutra Corp
Neutra Corp is a Houston-based public holding company (OTC: NTRR) that operates a Site Management Organization—subsidiary Neutra Life Sciences—running multi-therapeutic clinical research sites for pharmaceutical sponsors and CROs, including a flagship partnership with Parexel.
- Company typePublic
- Founded2011
- HeadquartersKaty, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Neutra Corp does
Neutra Corp (OTC: NTRR) is a publicly traded holding company headquartered in Houston, Texas (2500 CityWest Blvd, Ste 150-161), originally incorporated in 2011 as a research and development company in nutraceuticals, food and drug, and environmental purification markets. In 2025 the company executed a strategic pivot, launching wholly owned subsidiary Neutra Life Sciences—a Site Management Organization (SMO) that oversees clinical research sites across multiple therapeutic areas including Oncology, Dermatology, Pulmonology, and Women's Health. The SMO integrates proprietary Standard Operating Procedures with industry best practices to manage trial operations, patient experiences, and data delivery, and is delivered through a network of joint-venture research sites established with healthcare providers (e.g., Women's Healthcare Center of Baytown for women's health/OB-GYN research).
Revenue is generated primarily through contract-based clinical research services with pharmaceutical/biotech sponsors and Contract Research Organizations (CROs). The GTM model combines enterprise field sales to sponsors and CROs with a joint-venture site-buildout strategy. The January 2026 partnership with major CRO Parexel is the company's most prominent commercial relationship and is cited by management as the primary driver behind the projected 1,000% year-over-year revenue increase. Marketing and investor communications rely on press release distribution, an investor relations website, OTC Markets filings, and conference attendance (SCRS Global Site Solutions Summit, Obesity Week 2026). Additional growth vectors include a Letter of Intent to acquire CuraConnector.com, Inc. (April 2025) in healthcare information/digital technology, and ongoing site-network JV expansion. A July 2026 Securities Purchase Agreement Reversal and Debt Settlement with VIVIS Corporation indicates active balance-sheet management to redirect resources to the SMO subsidiary.
Neutra Corp firmographics
Firmographics- Name
- Neutra Corp
- Legal name
- Neutra Corp
- Website
- https://neutrainc.com
- Company type
- Public
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Neutra Corp is a Houston-based public holding company (OTC: NTRR) that operates a Site Management Organization—subsidiary Neutra Life Sciences—running multi-therapeutic clinical research sites for pharmaceutical sponsors and CROs, including a flagship partnership with Parexel.
- Ownership category
- akta.pro rank
Neutra Corp industry classification
Industry- Product category
- Clinical Research Services (Site Management Organization)
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169), Management Consulting Services (54161)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Management Services (8741)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Site Identification & Feasibility (HLAGACAB), Site Quality Management & Audit Readiness (HLAGACAN), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)
Keywords
Where Neutra Corp is headquartered
LocationHeadquarters
- HQ city
- Katy
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Neutra Corp business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Clinical Research Contract Services: Neutra Life Sciences generates revenue through contract-based clinical research services. The subsidiary receives awards for clinical trials across multiple therapeutic areas (Oncology, Dermatology, Pulmonology, Women's Health) and signs contracts with sponsors and CROs. The company projects significant revenue growth driven by its expanding trial portfolio and multi-site network.
- Joint Venture Research Sites: Revenue is generated through joint venture partnerships with healthcare providers like Women's Healthcare Center of Baytown, where Neutra Life Sciences establishes dedicated research sites focused on specific therapeutic areas, generating additional revenue streams through contract-based research.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Neutra Corp product offering
Product offeringCore offering
Neutra Corp, through its wholly owned subsidiary Neutra Life Sciences, operates a Site Management Organization (SMO) that oversees multiple clinical research sites across therapeutic areas including Oncology, Dermatology, Pulmonology, and Women's Health. The company delivers contract-based clinical trial management and execution services to pharmaceutical/biotech sponsors and Contract Research Organizations (CROs), integrating proprietary Standard Operating Procedures with industry best practices to optimize trial operations, patient experiences, and data quality.
Product overview
Neutra Corp operates as a life sciences and healthcare technology company with a diversified portfolio centered on life sciences technology and Site Management Organization (SMO) operations. The company's primary offering is its wholly owned subsidiary Neutra Life Sciences, which functions as a comprehensive SMO managing clinical research sites across various specialties including oncology, dermatology, pulmonology, and women's health. The subsidiary integrates proprietary Standard Operating Procedures (SOPs) with industry best practices to optimize trial operations, enhance patient experiences, and deliver high-quality clinical data.
Differentiator
Problem solved
Functional benefit
Brands
- Neutra Life Sciences: Clinical research site management organization (SMO) comprised of multiple clinical research sites across various specialties, dedicated to transforming clinical research through a patient-centric approach.
Products and services
- Neutra Life Sciences Site Management Organization (SMO) Services
- Specialty Clinical Research Site Operations (Women's Health / OB-GYN)
Quantifiable outcome
- Projected over 1,000% revenue increase year-over-year
Companies that use Neutra Corp
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Neutra Corp technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Neutra Corp partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Women's Healthcare Center of BaytowncoreNeutra Life Sciences formed a joint venture with Women's Healthcare Center of Baytown to open a research site focused on women's health and OB/GYN specialties in Baytown, Texas. The joint venture establishes a dedicated women's health research site as part of the expanding clinical trial network.
- ParexelcoreNeutra Corp partnered with Parexel, a leading CRO, to enhance its clinical trial capabilities. This partnership is credited as a key driver of the company's projected 1,000% revenue increase and represents a significant strategic relationship with a major CRO player.
Scale indicators3 records
Recent moves9 records
Expansion highlights6 records
Neutra Corp competitors and assessment
Company assessmentDirect peers
- Sarah Cannon Research Institute: Sarah Cannon is a leading oncology-focused Site Management Organization running community-based clinical trials across the US. It is comparable to Neutra Life Sciences in oncology-specific site management and shares the multi-site JV-style operating model.
- Velocity Clinical Research: Velocity Clinical Research is a multi-therapeutic Site Management Organization operating integrated research sites across the United States. It is the closest direct peer to Neutra Life Sciences, competing head-to-head for sponsor and CRO trial placement across similar therapeutic areas.
- DM Clinical Research: DM Clinical Research operates a multi-site clinical research network in Texas and surrounding states, focused on multi-therapeutic trial execution. It directly competes with Neutra Life Sciences for trial placement in the same regional footprint and therapeutic areas.
Broad incumbents
- IQVIA: IQVIA is the largest global CRO with a substantial site management and clinical operations footprint, including its Patient Recruitment Site Network and integrated clinical delivery platform. It competes with Neutra Life Sciences for trial placement and represents the upper bound of scale and capability in this space.
- Medpace: Medpace is a mid-to-large CRO with strong site-management operations focused on Phase II–IV trials across multiple therapeutic areas. It competes with Neutra Life Sciences for sponsor awards and operates a similar trial-execution model.
- ICON plc: ICON is a top-tier global CRO with site management, decentralized trial, and patient-recruitment capabilities following its PRA Health Sciences acquisition. It overlaps with Neutra Life Sciences on multi-TA trial execution and SMO services to sponsors.
- WCG (WIRB-Copernicus Group): WCG provides site-focused services including IRB review, IBC review, and clinical technology that supports site operations across the industry. It is adjacent to Neutra Life Sciences' SMO operations and overlaps in serving the same clinical research site customer base.
- Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization offering both CRO and commercial services, including site management and patient recruitment. It is broadly comparable to Neutra Life Sciences in multi-TA trial execution and site-network services.
Emerging players
- Florence Healthcare: Florence Healthcare provides site-focused clinical trial technology (eTMF, eRegulatory) that supports site operations across the research industry. It is adjacent to Neutra Life Sciences in serving the same site-network customer base and addressing site-management inefficiencies.
- Clinipace Worldwide: Clinipace is a mid-sized CRO with site management and biometrics capabilities serving small-to-mid biopharma sponsors. Comparable to Neutra Life Sciences in competing for trial awards from emerging biopharma sponsors with similar multi-TA focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Neutra Corp social profiles
Digital presenceNeutra Corp financial estimates
Financial estimateRevenue estimate
Valuation estimate
Neutra Corp leadership team
Management profileNumber of profiles
Profiles1 record
Neutra Corp subsidiaries and ownership
Company hierarchySubsidiaries1 record
Neutra Corp funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Neutra Corp M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Neutra Corp
What does Neutra Corp do?
Neutra Corp, through its wholly owned subsidiary Neutra Life Sciences, operates a Site Management Organization (SMO) that oversees multiple clinical research sites across therapeutic areas including Oncology, Dermatology, Pulmonology, and Women's Health. The company delivers contract-based clinical trial management and execution services to pharmaceutical/biotech sponsors and Contract Research Organizations (CROs), integrating proprietary Standard Operating Procedures with industry best practices to optimize trial operations, patient experiences, and data quality.
Is Neutra Corp a public or private company?
Neutra Corp is a public company. It is classified as public and is currently operating.
When was Neutra Corp founded?
Neutra Corp was founded in 2011. It employs 1 to 10 people.
Where is Neutra Corp based?
Neutra Corp is headquartered in Katy, United States, in the North America region.
How does Neutra Corp make money?
Two revenue lines are on record. Clinical Research Contract Services are the primary driver. The others are joint Venture Research Sites.
Who are Neutra Corp's main competitors?
Direct peers on record are Sarah Cannon Research Institute, Velocity Clinical Research and DM Clinical Research. Broad incumbents are IQVIA, Medpace, ICON plc, WCG (WIRB-Copernicus Group) and Syneos Health. Emerging players are Florence Healthcare and Clinipace Worldwide.
Does Neutra Corp have an API?
No public API is recorded for Neutra Corp.
What industry is Neutra Corp in?
Neutra Corp's product category is Clinical Research Services (Site Management Organization). Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAB, Site Identification & Feasibility. Its NAICS code is 5417 and its SIC code is 8731.